Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...

Microorganisms in Medicine and Therapeutics

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.

Site-Targeted Drug Delivery Systems: Polymeric Carriers

Site-Targeted Drug Delivery Systems: Polymeric Carriers

Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Erratum to "Epigallocathechin-3 gallate inhibits cardiac hypertrophy through blocking reactive oxidative species-dependent and -independent signal pathways" [Free Radical Biol. Med. 40 (2006) 1756-1775].

Free radical biology & medicine·2020

Same author

Human Clinical Relevance of the Porcine Model of Pseudoallergic Infusion Reactions.

Biomedicines·2020

Same author

Protein Nanotubes: From Bionanotech towards Medical Applications.

Biomedicines·2019

Same author

The role of angiotensin II and TGF-beta on the progression of chronic allograft nephropathy.

Journal of the renin-angiotensin-aldosterone system : JRAAS·2017

Same author

Prenatal inflammation-induced NF-κB dyshomeostasis contributes to renin-angiotensin system over-activity resulting in prenatally programmed hypertension in offspring.

Scientific reports·2016

Same author

Nucleic acid-based aptamers: applications, development and clinical trials.

Current medicinal chemistry·2015

Search research articles

Related Experiment Video

Updated: Jul 11, 2026

Mechanical Dissociation of Tissues for Single Cell Analysis Using a Motorized Device

Mechanical Dissociation of Tissues for Single Cell Analysis Using a Motorized Device

Published on: November 10, 2023

Recent advances in basic and clinical nanomedicine.

K John Morrow¹, Raj Bawa, Chiming Wei

¹Newport Biotechnology Consultants, 625 Washington Avenue, Newport, KY 41071, USA.

The Medical Clinics of North America

|September 11, 2007

Summary

Nanomedicine, a growing field, involves nanotechnology applications in healthcare. While commercialization faces challenges, advances in drug delivery and diagnostics signal a transformative future for medicine.

More Related Videos

A Comprehensive Procedure to Evaluate the In Vivo Performance of Cancer Nanomedicines

A Comprehensive Procedure to Evaluate the In Vivo Performance of Cancer Nanomedicines

Published on: March 4, 2017

Surface-enhanced Resonance Raman Scattering Nanoprobe Ratiometry for Detecting Microscopic Ovarian Cancer via Folate Receptor Targeting

Surface-enhanced Resonance Raman Scattering Nanoprobe Ratiometry for Detecting Microscopic Ovarian Cancer via Folate Receptor Targeting

Published on: March 25, 2019

Related Experiment Videos

Last Updated: Jul 11, 2026

Mechanical Dissociation of Tissues for Single Cell Analysis Using a Motorized Device

Mechanical Dissociation of Tissues for Single Cell Analysis Using a Motorized Device

Published on: November 10, 2023

A Comprehensive Procedure to Evaluate the In Vivo Performance of Cancer Nanomedicines

A Comprehensive Procedure to Evaluate the In Vivo Performance of Cancer Nanomedicines

Published on: March 4, 2017

Surface-enhanced Resonance Raman Scattering Nanoprobe Ratiometry for Detecting Microscopic Ovarian Cancer via Folate Receptor Targeting

Surface-enhanced Resonance Raman Scattering Nanoprobe Ratiometry for Detecting Microscopic Ovarian Cancer via Folate Receptor Targeting

Published on: March 25, 2019

Area of Science:

Biotechnology
Materials Science
Medical Technology

Background:

Nanomedicine is emerging as a significant global enterprise with substantial industrial and governmental interest.
The diverse nature of nanotechnology, encompassing a cluster of technologies, necessitates a clear and unified definition.
Numerous nanomedicine applications are in development, indicating a strong pipeline for future medical innovations.

Purpose of the Study:

To highlight the current landscape and future potential of nanomedicine.
To address the definitional challenges within nanotechnology.
To underscore the ongoing transition of nanomedicine research into clinical practice.

Main Methods:

Review of current nanomedicine research and development trends.
Analysis of the challenges in translating nanomedicine research into commercial products.
Identification of key areas of advancement, including drug delivery, diagnostics, and drug development.

Main Results:

Nanomedicine represents a burgeoning global market with increasing investment.
A clear definition of nanotechnology is crucial due to its multifaceted nature.
Despite developmental hurdles, significant progress is evident in nanomedicine applications.

Conclusions:

Nanomedicine holds immense potential to revolutionize healthcare, despite a long path to full realization.
Advances in nanotechnology are beginning to reshape medical practices, particularly in targeted drug delivery and personalized medicine.
Continued research and development are essential to overcome challenges and unlock the full capabilities of nanomedicine.